“Hope lies in dreams, in imagination, and in the courage of those who dare to make dreams into reality.” – Jonas Salk



Tavotek is funded by leading biotech investors that believe in the world-changing, next generation approach of our platforms and cancer treatments. 

Over $75 million has been raised in Series A and B funding since the company’s inception. The establishment of these long-lasting relationships have been a driving force in our growth.

727 Norristown Road, 3 Spring House Innovation Park Suite 101, Lower Gwynedd, Pennsylvania 19002

China. Suzhou. Suzhou Industrial Park. Unit 405, Building C2, No. 218, Xinghu Street

© 2023 Tavotek Biotherapeutics All rights reserved.   (267) 405-9426

© 2023 Tavotek Biotherapeutics All rights reserved.(267) 405-9426